Literature DB >> 21430110

Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?

Michael Weller, Wolfgang Wick.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21430110      PMCID： PMC3064701          DOI： 10.1093/neuonc/nor019

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  Mgmt methylation is a prognostic biomarker in elderly patients with newly diagnosed glioblastoma.

Authors:  E R Gerstner; S Yip; D L Wang; D N Louis; A J Iafrate; T T Batchelor
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

2.  Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases.

Authors:  Jacob G Scott; John H Suh; Paul Elson; Gene H Barnett; Michael A Vogelbaum; David M Peereboom; Gene H J Stevens; Heinrich Elinzano; Samuel T Chao
Journal:  Neuro Oncol       Date:  2011-03-01       Impact factor: 12.300

3.  Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Authors:  Christian Hartmann; Bettina Hentschel; Wolfgang Wick; David Capper; Jörg Felsberg; Matthias Simon; Manfred Westphal; Gabriele Schackert; Richard Meyermann; Torsten Pietsch; Guido Reifenberger; Michael Weller; Markus Loeffler; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2010-11-19       Impact factor: 17.088

4.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

5.  Radiotherapy for glioblastoma in the elderly.

Authors:  Florence Keime-Guibert; Olivier Chinot; Luc Taillandier; Stéphanie Cartalat-Carel; Marc Frenay; Guy Kantor; Jean-Sébastien Guillamo; Eric Jadaud; Philippe Colin; Pierre-Yves Bondiau; Philippe Meneï; Hugues Loiseau; Valérie Bernier; Jérôme Honnorat; Maryline Barrié; Karima Mokhtari; Jean-Jacques Mazeron; Anne Bissery; Jean-Yves Delattre
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245
  5 in total
  3 in total

1.  Radiologic image-based statistical shape analysis of brain tumours.

Authors:  Karthik Bharath; Sebastian Kurtek; Arvind Rao; Veerabhadran Baladandayuthapani
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-03-15       Impact factor: 1.864

2.  Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?

Authors:  Marc Zanello; Alexandre Roux; Renata Ursu; Sophie Peeters; Luc Bauchet; Georges Noel; Jacques Guyotat; Pierre-Jean Le Reste; Thierry Faillot; Fabien Litre; Nicolas Desse; Evelyne Emery; Antoine Petit; Johann Peltier; Jimmy Voirin; François Caire; Jean-Luc Barat; Jean-Rodolphe Vignes; Philippe Menei; Olivier Langlois; Edouard Dezamis; Antoine Carpentier; Phong Dam Hieu; Philippe Metellus; Johan Pallud
Journal:  J Neurooncol       Date:  2017-07-19       Impact factor: 4.130

3.  Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma.

Authors:  Miyuki Uno; Sueli Mieko Oba-Shinjo; Anamaria Aranha Camargo; Ricardo Pereira Moura; Paulo Henrique de Aguiar; Hector Navarro Cabrera; Marcos Begnami; Sérgio Rosemberg; Manoel Jacobsen Teixeira; Suely Kazue Nagahashi Marie
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.